Cipla surprises with strong earnings; L&T, BHEL ride on infra boom, says Anand Rathis Narendra Solanki

Narendra Solanki, Head of Fundamental Research at Anand Rathi Shares, remains bullish on L&T and BHEL amid strong government capex momentum. Ciplas results exceeded expectations despite a surprise leadership change, while Dr Reddys stock fell after a key GLP-1 drug approval was delayed. Solanki expects stable macros and selective sectoral opportunities ahead.